The sphingolipid ceramide, a bioeffector lipid, is known to regulate anti-proliferative and stress responses in various human cancer cells. Studies from this project have defined a novel pathway for the generation of ceramide, 'the salvage pathway', which involves activation of acid sphingomyelinase (aSMase). Interestingly, our preliminary results show that the cytotoxic agents cisplatin, doxorubicin, and paclitaxel exert significant effects on the adhesion and migration of cancer cells, at sub-toxic concentrations. Importantly, these results suggest an important role for the aSMase/ceramide pathway in regulating these responses. These data and insights lead us to the HYPOTHESIS that the aSMase/ceramide pathway is an important mediator of stress inducers, with key roles in regulating cell migration and metastasis. Therefore, 3 specific aims are proposed: 1) To define molecular mechanisms of activation of aSMase. We will focus on defining a) the role of PKC3 as an upstream kinase in regulation of aSMase;b) the biochemical and cellular mechanisms by which phosphorylation activates the enzyme;and c) the cellular compartment where aSMase is activated. 2) To determine the role of aSMase in tumor growth and metastasis and response to chemotherapy by: a) establishing the role of aSMase/ceramide in cell adhesion/migration of cancer cells;b) examining and defining the role of this pathway in tumor metastasis/growth in vivo. 3) To determine the mechanisms by which the aSMase/ceramide pathway mediates cell stress responses. Understanding this pathway should have great impact on the field of ceramide-mediated biology precisely by beginning to untangle the complexity of these pathways through provision of pathway-specific insight. Equally as important, defining upstream and downstream components of this pathway, which is activated by agents of significant therapeutic value, may result in defining novel therapeutic targets in cancer therapy. Finally, there is the tantalizing possibility that the role of this pathway in inhibition of cell migration in response to chemotherapeutic agents may lead to a re-examination of therapeutically relevant actions of these agents by focusing on their effects on migration and metastasis rather than on cytotoxicity or proliferation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
7P01CA097132-10
Application #
8381023
Study Section
Special Emphasis Panel (ZCA1-RPRB-O)
Project Start
Project End
2014-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
10
Fiscal Year
2012
Total Cost
$191,961
Indirect Cost
$37,225
Name
State University New York Stony Brook
Department
Type
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Lu, Songjian; Cai, Chunhui; Yan, Gonghong et al. (2016) Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations. Cancer Res 76:6785-6794
Carroll, Brittany L; Pulkoski-Gross, Michael J; Hannun, Yusuf A et al. (2016) CHK1 regulates NF-κB signaling upon DNA damage in p53- deficient cells and associated tumor-derived microvesicles. Oncotarget 7:18159-70
Xu, Ruijuan; Wang, Kai; Mileva, Izolda et al. (2016) Alkaline ceramidase 2 and its bioactive product sphingosine are novel regulators of the DNA damage response. Oncotarget 7:18440-57
García-Barros, Mónica; Coant, Nicolas; Kawamori, Toshihiko et al. (2016) Role of neutral ceramidase in colon cancer. FASEB J 30:4159-4171
McCracken, A N; McMonigle, R J; Tessier, J et al. (2016) Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation. Leukemia :
Adada, Mohamad; Luberto, Chiara; Canals, Daniel (2016) Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases. Chem Phys Lipids 197:45-59
Espaillat, Mel Pilar; Kew, Richard R; Obeid, Lina M (2016) Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis. Adv Biol Regul :
Wang, K; Xu, R; Snider, A J et al. (2016) Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune system. Cell Death Dis 7:e2124
Kitatani, K; Usui, T; Sriraman, S K et al. (2016) Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid. Oncogene 35:2801-12
Wu, Song; Powers, Scott; Zhu, Wei et al. (2016) Substantial contribution of extrinsic risk factors to cancer development. Nature 529:43-7

Showing the most recent 10 out of 172 publications